Clinical picture of the duration of venoarterial extracorporeal membrane oxygenation: analysis from JROAD-DPC.
Cardiovascular diseases
Duration
Extracorporeal membrane oxygenation
Multicenter study
Shock
Journal
Heart and vessels
ISSN: 1615-2573
Titre abrégé: Heart Vessels
Pays: Japan
ID NLM: 8511258
Informations de publication
Date de publication:
Feb 2023
Feb 2023
Historique:
received:
31
01
2022
accepted:
18
08
2022
pubmed:
30
9
2022
medline:
10
1
2023
entrez:
29
9
2022
Statut:
ppublish
Résumé
Venoarterial extracorporeal membrane oxygenation (VA-ECMO) has been widely used for critically ill patients all over the world; however, comprehensive survey regarding the relationship between VA-ECMO duration and prognosis is limited. We conducted a survey of VA-ECMO patients in the Japanese Registry of All Cardiac and Vascular Diseases-Diagnosis Procedure Combination (JROAD-DPC), which was a health insurance claim database study among cardiovascular centers associated with the Japan Circulation Society, between April 2012 and March 2016. Out of 13,542 VA-ECMO patients, we analyzed 5766 cardiovascular patients treated with VA-ECMO. 68% patients used VA-ECMO only for 1 day and 93% had VA-ECMO terminated within 1 week. In multivariate analysis, the hazard ratio of 1-day support was significantly high at 1.72 (95% confidence intervals; 95% CI 1.53-1.95) (p < 0.001), while that of 2-day [0.60 (95% CI 0.49-0.73)], 3-day [0.75 (95% CI 0.60-0.94)], 4-day [0.43 (95% CI 0.31-0.60)] and 5-day support [0.62 (95% CI 0.44-0.86)] was significantly low. Comprehensive database analysis of JROAD-DPC revealed that cardiovascular patients who were supported with VA-ECMO for 2-5 days showed lower mortality. The optimal VA-ECMO support window should be investigated in further studies.
Identifiants
pubmed: 36173448
doi: 10.1007/s00380-022-02158-0
pii: 10.1007/s00380-022-02158-0
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
228-235Informations de copyright
© 2022. Springer Japan KK, part of Springer Nature.
Références
Guglin M, Zucker MJ, Bazan VM, Bozkurt B, Banayosy AE, Estep JD, Gurley J, Nelson K, Malyala R, Panjrath GS, Zwischenberger JB, Pinney SP (2019) Venoarterial ECMO for adults: JACC scientific expert panel. J Am Coll Cardiol 73:698–716
doi: 10.1016/j.jacc.2018.11.038
Chang CH, Chen HC, Caffrey JL, Hsu J, Lin JW, Lai MS, Chen YS (2016) Survival analysis of extracorporeal membrane oxygenation in neonatal and pediatric patients: a nationwide cohort study. Circulation 133:2423–2433
doi: 10.1161/CIRCULATIONAHA.115.019143
Schmidt M, Burrell A, Roberts L, Bailey M, Sheldrake J, Rycus PT, Hodgson C, Scheinkestel C, Cooper DJ, Thiagarajan RR, Brodie D, Pellegrino V, Pilcher D (2015) Predicting survival after ECMO for refractory cardiogenic shock: the survival after veno-arterial-ECMO (SAVE)-score. Eur Heart J 36:2246–2256
doi: 10.1093/eurheartj/ehv194
Nakashima T, Noguchi T, Tahara Y, Nishimura K, Ogata S, Yasuda S, Onozuka D, Morimura N, Nagao K, Gaieski DF, Asai Y, Yokota H, Nara S, Hase M, Atsumi T, Sakamoto T, for the SAVE-J Group Patients (2019) Patients with refractory out-of-cardiac arrest and sustained ventricular fibrillation as candidates for extracorporeal cardiopulmonary resuscitation - prospective multi-center observational study. Circ J 83:1011–1018
doi: 10.1253/circj.CJ-18-1257
Sanaiha Y, Bailey K, Downey P, Seo YJ, Aguayo E, Dobaria V, Shemin R, Benharash P (2019) Trends in mortality and resource utilization for extracorporeal membrane oxygenation in the United States: 2008–2014. Surgery 165:381–388
doi: 10.1016/j.surg.2018.08.012
Rao P, Khalpey Z, Smith R, Burkhoff D, Kociol RD (2018) Venoarterial extracorporeal membrane oxygenation for cardiogenic shock and cardiac arrest. Circ Heart Fail 11(9):e004905
doi: 10.1161/CIRCHEARTFAILURE.118.004905
Cheng R, Hachamovitch R, Kittleson M, Patel J, Arabia F, Moriguchi J, Esmailian F, Azarbal B (2014) Complications of extracorporeal membrane oxygenation for treatment of cardiogenic shock and cardiac arrest: a meta-analysis of 1,866 adult patients. Ann Thorac Surg 97:610–616
doi: 10.1016/j.athoracsur.2013.09.008
Rastan AJ, Dege A, Mohr M, Doll N, Falk V, Walther T, Mohr FW (2010) Early and late outcomes of 517 consecutive adult patients treated with extracorporeal membrane oxygenation for refractory postcardiotomy cardiogenic shock. J Thorac Cardiovasc Surg 139:302–311
doi: 10.1016/j.jtcvs.2009.10.043
Smith M, Vukomanovic A, Brodie D, Thiagarajan R, Rycus P, Buscher H (2017) Duration of veno-arterial extracorporeal life support (VA ECMO) and outcome: an analysis of the extracorporeal life support organization (ELSO) registry. Crit Care 21:45
doi: 10.1186/s13054-017-1633-1
Gupta P, Robertson MJ, Beam B, Gossett JM, Schmitz ML, Carroll CL, Edwards JD, Fortenberry JD, Butt W (2015) Relationship of ECMO duration with outcomes after pediatric cardiac surgery: a multi-institutional analysis. Minerva Anestesiol 81:619–627
Distelmaier K, Wiedemann D, Binder C, Haberl T, Zimpfer D, Heinz G, Koinig H, Felli A, Steinlechner B, Niessner A, Laufer G, Lang IM, Goliasch G (2018) Duration of extracorporeal membrane oxygenation support and survival in cardiovascular surgery patients. J Thorac Cardiovasc Surg 155:2471–2476
doi: 10.1016/j.jtcvs.2017.12.079
Yasuda S, Nakao K, Nishimura K, Miyamoto Y, Sumita Y, Shishido T, Anzai T, Tsutsui H, Ito H, Komuro I, Saito Y, Ogawa H, on the behalf of JROAD Investigators (2016) The current status of cardiovascular medicine in Japan- analysis of a large number of health records from a nationwide claim-based database, JROAD-DPC. Circ J 80:2327–2335
doi: 10.1253/circj.CJ-16-0196
Yasuda S, Miyamoto Y, Ogawa H (2018) Current status of cardiovascular medicine in the aging society of Japan. Circulation 138:965–967
doi: 10.1161/CIRCULATIONAHA.118.035858
Ohta T, Waga S, Handa W, Saito I, Takeuchi K (1974) New grading of level of disordered consciousness (author’s transl). No Shinkei Geka 2:623–627
Eckman PM, Katz JN, Banayosy AE, Bohula EA, Sun B, Diepen S (2019) Veno-arterial extracorporeal membrane oxygenation for cardiogenic shock: an introduction for the busy clinician. Circulation 140:2019–2037
doi: 10.1161/CIRCULATIONAHA.119.034512
Kurihara C, Kawabori M, Sugiura T, Critsinelis AC, Wang S, Cohn WE, Civitello AB, Frazier OH, Morgan JA (2018) Bridging to a long-term ventricular assist device with short-term mechanical circulatory support. Artif Organs 42:589–596
doi: 10.1111/aor.13112
Chung M, Zhao Y, Strom JB, Shen C, Yeh RW (2019) Extracorporeal membrane oxygenation use in cardiogenic shock: impact of age on in-hospital mortality, length of stay, and costs. Crit Care Med 47:e214–e221
doi: 10.1097/CCM.0000000000003631
Yukawa T, Sugiyama K, Miyazaki K, Tanabe T, Ishikawa S, Hamabe Y (2018) Treatment of a patient with acute aortic dissection using extracorporeal cardiopulmonary resuscitation after an out-of-hospital cardiac arrest: a case report. Acute Med Surg 5:189–193
doi: 10.1002/ams2.324
George B, Parazino M, Omar HR, Davis G, Guglin M, Gurley J, Smyth S (2018) A retrospective comparison of survivors and non-survivors of massive pulmonary embolism receiving veno-arterial extracorporeal membrane oxygenation support. Resuscitation 122:1–5
doi: 10.1016/j.resuscitation.2017.11.034
Massetti M, Tasle M, Page OL, Deredec R, Babatasi G, Buklas D, Thuaudet S, Charbonneau P, Hamon M, Grollier G, Gerard JL, Khayat A (2005) Back from irreversibility: extracorporeal life support for prolonged cardiac arrest. Ann Thorac Surg 79:178–183
doi: 10.1016/j.athoracsur.2004.06.095
Kuroki N, Abe D, Iwama T, Sugiyama K, Akashi A, Hamabe Y, Aonuma K, Sato A (2016) Prognostic effect of estimated glomerular filtration rate in patients with cardiogenic shock or cardiac arrest undergoing percutaneous veno-arterial extracorporeal membrane oxygenation. J Cardiol 68:439–446
doi: 10.1016/j.jjcc.2015.10.014
Patel SM, Lipinski J, Al-Kindi SG, Patel T, Saric P, Li J, Nadeem F, Ladas T, Alaiti A, Phillips A, Medalion B, Deo S, Elgudin Y, Costa MA, Osman MN, Attizzani GF, Oliveira GH, Sareyyupoglu B, Bezerra HG (2019) Simultaneous venoarterial extracorporeal membrane oxygenation and percutaneous left ventricular decompression therapy with impella is associated with improved outcomes in refractory cardiogenic shock. ASAIO J 65:21–28
doi: 10.1097/MAT.0000000000000767
Kuo G, Chen SW, Fan PC, Wu VCC, Chou AH, Lee CC, Chu PH, Tsai FC, Tian YC, Chang CH (2019) Analysis of survival after initiation of continuous renal replacement therapy in patients with extracorporeal membrane oxygenation. BMC Nephrol 20:318
doi: 10.1186/s12882-019-1516-6
Wang L, Xing Z (2019) Short-term outcomes of intra-aortic balloon pump combined with venoarterial extracorporeal membrane oxygenation: a systematic review and meta-analysis. Artif Organs 43:561–568
doi: 10.1111/aor.13397
Kern KB, Hilwig RW, Rhee KH, Berg RA (1996) Myocardial dysfunction after resuscitation from cardiac arrest: an example of global myocardial stunning. J Am Coll Cardiol 28:232–240
doi: 10.1016/0735-1097(96)00130-1
Oude Lansink-Hartgring A, de Vries AJ, Droogh JM, van den Bergh WM (2019) Hemorrhagic complications during extracorporeal membrane oxygenation - The role of anticoagulation and platelets. J Crit Care 54:239–243
doi: 10.1016/j.jcrc.2019.09.013
Meltzer EC, Ivascu NS, Stark M, Orfanos AV, Acres CA, Christos PJ, Mangione T, Fins JJ (2016) A survey of physicians’ attitudes toward decision-making authority for initiating and withdrawing VA-ECMO: results and ethical implications for shared decision making. J Clin Ethics 27:281–289
doi: 10.1086/JCE2016274281
Godfrey S, Sahoo A, Sanchez J, Fried J, Masoumi A, Brodie D, Takayama H, Uriel N, Takeda K, Nakagawa S (2021) The role of palliative care in withdrawal of venoarterial extracorporeal membrane oxygenation for cardiogenic shock. J Pain Symptom Manage 61:1139–1146
doi: 10.1016/j.jpainsymman.2020.10.027